This site is intended for healthcare professionals only

New An in-depth review discussing two posters presented at ESC 2019

With

Søren Paaske Johnsen

With

Daniele Pastori

Approx. time required 60 mins
Watch now

New Bleeding and new cancer diagnosis in patients with atherosclerosis

With

John Eikelboom

Approx. time required 30 mins
Watch now

New Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

With

Stuart Connolly

Approx. time required 30 mins
Watch now

Betrixaban versus enoxaparin for VTE in critically ill patients: an APEX substudy

With

Russell Hull

Approx. time required 30 mins
Watch now

Therapy with non-vitamin K oral anticoagulants (NOACs) gives us with the best opportunity that we have had to increase anticoagulation for patient with at-risk atrial fibrillation and greatly reduce stroke burden that complicates this arrhythmia.

Professor John Camm, NOAC Faculty member